Clinical evidence suggests that continuing medication indefinitely produces the most durable results and prevents the 50-70% weight rebound seen in dietary-only interventions
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
When she told me about the experience she had with the staff and the doctors bedside manner, I felt more confident about trying something new for my own ailments Sarah B
Individuals with very low body weight (relative to typical GLP-1 trial populations) may also benefit
Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: a systematic review and meta-analysis
Betaine enhanced fatty acids oxidation as evidenced by the increase in the expression of carnitine palmitoyltransferase 1 (CPT1, a key regulatory enzyme in fatty acid -oxidation) and other regulatory proteins: PPAR, FGF21, and AMPK in the liver (Xu et al., 2015b)
